Improving HIV outcomes by reducing unhealthy alcohol use
CETA-CORE
['FUNDING_P01'] · UNIVERSITY OF ALABAMA AT BIRMINGHAM · NIH-10915737
This study is looking at how to help people with HIV cut down on unhealthy drinking, using a special treatment method, so they can feel better overall, and it’s designed for both patients and healthcare providers in places like sub-Saharan Africa and the United States.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ALABAMA AT BIRMINGHAM (nih funded) |
| Locations | 1 site (BIRMINGHAM, UNITED STATES) |
| Trial ID | NIH-10915737 on ClinicalTrials.gov |
What this research studies
This research focuses on addressing the significant issue of unhealthy alcohol use, which complicates the management of HIV in both sub-Saharan Africa and the United States. It employs a treatment model known as the Common Elements Treatment Approach (CETA) to help individuals reduce their alcohol consumption while simultaneously improving their HIV clinical outcomes. The project includes training healthcare providers in this approach and evaluating its effectiveness across different demographics and clinical settings. By integrating alcohol reduction interventions into HIV care, the research aims to enhance the overall health and well-being of affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are living with HIV and struggle with unhealthy alcohol use.
Not a fit: Patients who do not have HIV or do not engage in unhealthy alcohol use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for individuals living with HIV by effectively reducing alcohol use.
How similar studies have performed: Previous research has shown that integrated treatment approaches for alcohol use and HIV management can be effective, suggesting a promising avenue for this study.
Where this research is happening
BIRMINGHAM, UNITED STATES
- UNIVERSITY OF ALABAMA AT BIRMINGHAM — BIRMINGHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MURRAY, LAURA KAY — UNIVERSITY OF ALABAMA AT BIRMINGHAM
- Study coordinator: MURRAY, LAURA KAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus